Keyword: Virtus Pharmaceuticals
Generic drugmaker Virtus Pharmaceuticals recently asked the FDA in a Citizens Petition to hold up on its plan to remove unapproved generic versions of potassium chloride from the market. Now it has filed a lawsuit demanding the FDA the FDA put the brakes on.
Elected officials have been publicly bludgeoning drugmakers they say have used monopoly power to jack up drug prices. Meanwhile, in the background, a generic drugmaker is turning the argument against a competitor, accusing it of pulling a fast one on the FDA to win approval of a drug and setting itself and its partners up to control the market.
Tampa, FL-based Virtus Pharmaceuticals is recalling an intestinal treatment drug which it said failed potency tests and has been linked to several adverse reports of hallucinations or stroke-like symptoms.